BioSpace News Archive

Biotech Bay

23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting

23andMe Holding Co. today announced that it will present a trials-in-progress poster presentation on 23ME-00610, an investigational antibody targeting CD200R1, at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting to be held in Boston, MA .

October 5, 2022
·
4 min read
Longeveron to Present at the Annual Dawson James Small Cap Growth Conference

Longeveron Inc. announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming Dawson James Small Cap Growth Conference taking place in Jupiter, Florida from October 11-12, 2022.

October 5, 2022
·
1 min read
Deals

Fortress Biotech Announces Timing of Regular Monthly Dividend for October, November and December 2022 for its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech, Inc. today announced its board of directors has declared the regular monthly dividend of $0.1953125 per share of the Company’s 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock.

October 5, 2022
·
4 min read
Business

Yield10 Bioscience Appoints Willie Loh, Ph.D., Former Cargill Executive, to the Board of Directors

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that Willie Loh, Ph.D., was named to the Company’s Board of Directors effective October 4, 2022.

October 5, 2022
·
4 min read
Biotech Bay

Mirum Pharmaceuticals to Present LIVMARLI® (maralixibat) Analyses and Host a Scientific Symposium at NASPGHAN 2022 Annual Meeting

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will present three posters and host a scientific symposium during the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting taking place October 12-16, 2022, in Orlando, Florida.

October 5, 2022
·
6 min read
Pharm Country

MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

Mind Medicine today announced that members of MindMed’s management team will participate in the Cantor Fitzgerald Neurology & Psychiatry Conference.

October 5, 2022
·
1 min read
BioMidwest

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices

cultivate Capital Funds LP announces that one of their portfolio companies, Grand Rapids, MI based HAPPE Spine was granted two more issued patents in a growing portfolio establishing HAPPE as the leader of next generation orthopaedic and spinal implants enabled by the HAPPETM platform.

October 5, 2022
·
4 min read
Drug Development

MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109MBX 2109 is in clinical development for treatment of hypoparathyroidism

MBX Biosciences, Inc. today announced that it has initiated the multiple ascending dose portion of its ongoing Phase 1 clinical trial of MBX 2109.

October 5, 2022
·
3 min read
Biotech Beach

AnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trials

AnaptysBio, Inc. today announced that GSK’s study PERLA met its primary endpoint of objective response rate (ORR) of dostarlimab plus chemotherapy versus pembrolizumab plus chemotherapy as assessed by blinded independent central review per RECIST v1.1.

October 5, 2022
·
6 min read
Biotech Bay

ProSomnus® Sleep Technologies to Participate at the Oppenheimer Private Company Showcase

ProSomnus Holdings Inc. today announced that Laing Rikkers, Executive Chairwoman and Co-Founder, is scheduled to participate at the Oppenheimer Private Company Showcase on October 17-18, 2022 at the Four Seasons in Palo Alto, California.

October 5, 2022
·
1 min read